Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Martus

Showing results (411-420 of 437) with videos related to

Pageof 44
Sort By:
JAMA Ophthalmology|May 1, 2020
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled TrialM Dominik Fischer, Stylianos Michalakis, Barbara Wilhelm, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 29, 2021
Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease SeverityHolger Hengel, Peter Martus, Jennifer Faber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Baseline Biomarkers for Outcome of Melanoma Patients Treated with PembrolizumabBenjamin Weide, Alexander Martens, Jessica C Hassel, et al.
Journal of Neurology|November 3, 2022
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factorsHolger Hengel, Peter Martus, Jennifer Faber, et al.
Journal of Neurology|November 18, 2023
Correction to: The frequency of non‑motor symptoms in SCA3 and their association with disease severity and lifestyle factorsHolger Hengel, Peter Martus, Jennifer Faber, et al.
Stroke|January 12, 2013
Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients studyArndt Rolfs, Franz Fazekas, Ulrike Grittner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2023
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical TrialConstantin Roder, Walter Stummer, Jan Coburger, et al.
BMC Neurology|November 12, 2013
The SCIentinel study--prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS)--study protocol and interim feasibility dataMarcel A Kopp, Claudia Druschel, Christian Meisel, et al.
The Lancet. Haematology|January 17, 2026
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 studyJonas S Heitmann, Yacine Maringer, Susanne Jung, et al.
Nature Communications|July 2, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 yearsClaus Garbe, Ulrike Keim, Teresa Amaral, et al.
Pageof 44

Showing results (411-420 of 437) with videos related to

Sort By:
Pageof 44
JAMA Ophthalmology|May 1, 2020
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled TrialM Dominik Fischer, Stylianos Michalakis, Barbara Wilhelm, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 29, 2021
Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease SeverityHolger Hengel, Peter Martus, Jennifer Faber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Baseline Biomarkers for Outcome of Melanoma Patients Treated with PembrolizumabBenjamin Weide, Alexander Martens, Jessica C Hassel, et al.
Journal of Neurology|November 3, 2022
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factorsHolger Hengel, Peter Martus, Jennifer Faber, et al.
Journal of Neurology|November 18, 2023
Correction to: The frequency of non‑motor symptoms in SCA3 and their association with disease severity and lifestyle factorsHolger Hengel, Peter Martus, Jennifer Faber, et al.
Stroke|January 12, 2013
Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients studyArndt Rolfs, Franz Fazekas, Ulrike Grittner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2023
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical TrialConstantin Roder, Walter Stummer, Jan Coburger, et al.
BMC Neurology|November 12, 2013
The SCIentinel study--prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS)--study protocol and interim feasibility dataMarcel A Kopp, Claudia Druschel, Christian Meisel, et al.
The Lancet. Haematology|January 17, 2026
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 studyJonas S Heitmann, Yacine Maringer, Susanne Jung, et al.
Nature Communications|July 2, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 yearsClaus Garbe, Ulrike Keim, Teresa Amaral, et al.
Pageof 44